Doctors share everything to know about the buzzy treatment.
Zacks Investment Research on MSN
EU approves Novo Nordisk's higher-dose Wegovy for obesity patients
Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of Wegovy (semaglutide injection) for adults with obesity. This provides physicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results